Summary
• Intelligent Bio Solutions Inc. (INBS) surged 12% in intraday trading to $6.17 following a reverse stock split announcement.
• The 1-for-10 reverse stock split will take effect at 11:59 PM on December 15, 2025, with trading under the adjusted INBS ticker starting December 16, 2025.
• The stock has shown high volatility with a yearly gain of 235%, despite a significant decline of nearly 97% over the past three years.
Intelligent Bio Solutions Inc. (NASDAQ: INBS) is experiencing a notable gain of 12% as it trades at $6.17, up from a prior close that was not available. This increase comes amidst routine trading, notably following the company’s announcement regarding a reverse stock split.
Reverse Stock Split Announcement Drives the Movement
On December 12, 2025, Intelligent Bio Solutions revealed that it would implement a 1-for-10 reverse stock split of its common shares. The split is set to take effect at 11:59 PM (Eastern Time) on December 15, 2025. The newly adjusted trading will commence under the INBS ticker on December 16, 2025. This strategic decision could be aimed at improving the stock’s appeal and trading dynamics.
The stock has shown considerable volatility recently, with weekly performance up 643% and monthly performance rising by 664%. With a calculated average volume of 108,228 in today’s trading session, the momentum is compelling.
[chart type=’price’ value=’INBS’]
Recent SEC Filings
The company filed an 8-K on December 16, 2025, which communicated details regarding the reverse stock split. This filing highlights ongoing compliance with SEC regulations, ensuring that investors are kept informed of important corporate actions that may affect their holdings.
[chart type=’sec’ value=’INBS’]
Market and Technical Overview
Currently, INBS is witnessing a dramatic yearly performance of 235%, despite its significant relative weakness over the three-year period, where it has dropped almost 97%. Currently, the stock’s volatility aligns closely with its ATR of 0.6. Historical context shows that the stock is trading significantly below its 52-week high, which reflects broad market pressures. The 14-day RSI is residing at 28.33, indicating potential oversold conditions.
The stock’s SMAs reflect substantial negative deviations, with the 20-day, 50-day, and 200-day SMAs showing considerable downtrends. This underscores a challenging technical environment, one that the announced reverse split aims to remedy.
Outlook
As Intelligent Bio Solutions moves through this critical transition period, investor attention will likely center on the outcomes of this reverse split and how it may affect liquidity and overall market sentiment. The company’s future performance hinges on its ability to leverage its technological offerings effectively and navigate the market challenges ahead.